Gut parasites are among the oldest and most common infections in
humans. Alterations in the host defense alterations caused by autoimmune
diseases or immunosuppressive drugs can cause modifications of the symptoms:
indolent parasites can be reactivated, asymptomatic patients may experience
new symptoms, or mild or moderate symptoms can become serious and, rarely,
may lead to death. In recent years, new drugs have been used in the
treatment of rheumatoid arthritis (RA), causing a greater level of
immunosuppression and therefore more concerns regarding the risk of serious
parasitic diseases. Of note, experimental studies have demonstrated that the
immunomodulation induced by infection with helminths can minimize the
occurrence and severity of rheumatoid arthritis. Products derived from
helminths (such as glycoprotein ES-62) can exert favorable effects in RA
patients via their anti-inflammatory actions. Greater knowledge of these
substances may serve as a basis for the development of new treatments for
RA. The full impact of parasitic diseases on patients with rheumatoid
arthritis remains controversial, and further studies are warrented.